Galvez-Sánchez Carmen M, Montoro Casandra I
Department of Psychology, University of Jaén, 23071 Jaén, Spain.
Behav Sci (Basel). 2023 May 15;13(5):415. doi: 10.3390/bs13050415.
Fibromyalgia Syndrome (FMS) is a chronic condition of widespread pain accompanied by several symptoms such as stiffness, fatigue, sleep problems, depression, anxiety, and cognitive deficits. To date, there is no specific treatment for FMS. The European League Against Rheumatism, and the majority of the international recommendations for managing FMS, has claimed psychoeducational intervention as the first step in FMS treatment for adequate symptoms management. However, scientific studies in this regard are scarce, diverse, and with contradictory findings. Results integration from analogous studies could provide a clear presentation of the real clinical value of psychoeducation in FMS. Therefore, the current systematic review aims at exploring the effect of psychoeducation on emotional, clinical, and functional symptoms of FMS patients and encourages researchers towards psychoeducation's procedure optimization and systematization. The systematic review was conducted according to the guidelines of the Cochrane Collaboration and PRISMA statements. The selected articles were evaluated using the Cochrane risk of bias (ROB) assessment tool. The selected articles were extracted from PubMed, Scopus, and Web of Science databases. The literature search identified 11 studies eligible for the systematic review. The ROB evaluation revealed that 2 of the 11 studies showed a low quality, the other 2 had a moderate quality, and the remaining 7 studies exhibited a high quality. Results showed that psychoeducation is generally included as an important first therapeutic step in multicomponent treatments for FMS. Moreover, psychoeducation generally seems to be quite beneficial in reducing emotional (i.e., number of days feeling emotionally well, general anxiety, depression levels, etc.) and clinical symptoms (levels of fatigue, morning stiffness, pain intensity, etc.), as well as increasing functional status (i.e., general physical function, morning fatigue, stiffness, etc.). Despite that psychoeducation´s clinical benefits are highlighted, there is scarce amount of research on psychoeducation beyond its usefulness as part of multicomponent treatments.
纤维肌痛综合征(FMS)是一种慢性疾病,伴有广泛疼痛,并伴有多种症状,如僵硬、疲劳、睡眠问题、抑郁、焦虑和认知缺陷。迄今为止,尚无针对FMS的特异性治疗方法。欧洲抗风湿病联盟以及大多数关于FMS管理的国际建议都主张将心理教育干预作为FMS治疗中进行充分症状管理的第一步。然而,这方面的科学研究很少,且各不相同,结果相互矛盾。对类似研究的结果整合可以清晰呈现心理教育在FMS中的实际临床价值。因此,当前的系统评价旨在探讨心理教育对FMS患者情绪、临床和功能症状的影响,并鼓励研究人员对心理教育的程序进行优化和系统化。该系统评价是根据Cochrane协作网和PRISMA声明的指南进行的。使用Cochrane偏倚风险(ROB)评估工具对所选文章进行评估。所选文章从PubMed、Scopus和科学网数据库中提取。文献检索确定了11项符合系统评价条件的研究。ROB评估显示,11项研究中有2项质量较低,另外2项质量中等,其余7项研究质量较高。结果表明,心理教育通常被纳入FMS多组分治疗的重要第一步。此外,心理教育在减轻情绪(即情绪良好的天数、一般焦虑、抑郁水平等)和临床症状(疲劳水平、晨僵、疼痛强度等)以及提高功能状态(即一般身体功能、晨疲劳、僵硬等)方面似乎通常非常有益。尽管心理教育的临床益处得到了强调,但除了作为多组分治疗一部分的有用性之外,关于心理教育的研究却很少。